Skip to main navigation Skip to search Skip to main content

Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1

  • Dylan M. Glubb
  • , Mel J. Maranian
  • , Kyriaki Michailidou
  • , Karen A. Pooley
  • , Kerstin B. Meyer
  • , Siddhartha Kar
  • , Saskia Carlebur
  • , Martin O'Reilly
  • , Joshua A. Betts
  • , Kristine M. Hillman
  • , Susanne Kaufmann
  • , Jonathan Beesley
  • , Sander Canisius
  • , John L. Hopper
  • , Melissa C. Southey
  • , Helen Tsimiklis
  • , Carmel Apicella
  • , Marjanka K. Schmidt
  • , Annegien Broeks
  • , Frans B. Hogervorst
  • C. Ellen Van Der Schoot, Kenneth Muir, Artitaya Lophatananon, Sarah Stewart-Brown, Pornthep Siriwanarangsan, Peter A. Fasching, Matthias Ruebner, Arif B. Ekici, Matthias W. Beckmann, Julian Peto, Isabel Dos-Santos-Silva, Olivia Fletcher, Nichola Johnson, Paul D.P. Pharoah, Manjeet K. Bolla, Qin Wang, Joe Dennis, Elinor J. Sawyer, Ian Tomlinson, Michael J. Kerin, Nicola Miller, Barbara Burwinkel, Frederik Marme, Rongxi Yang, Harald Surowy, Pascal Guénel, Thérèse Truong, Florence Menegaux, Marie Sanchez, Stig E. Bojesen, Børge G. Nordestgaard, Sune F. Nielsen, Henrik Flyger, Anna González-Neira, Javier Benitez, M. Pilar Zamora, Jose Ignacio Arias Perez, Hoda Anton-Culver, Susan L. Neuhausen, Hermann Brenner, Aida Karina Dieffenbach, Volker Arndt, Christa Stegmaier, Alfons Meindl, Rita K. Schmutzler, Hiltrud Brauch, Yon Dschun Ko, Thomas Brüning, Heli Nevanlinna, Taru A. Muranen, Kristiina Aittomäki, Carl Blomqvist, Keitaro Matsuo, Hidemi Ito, Hiroji Iwata, Hideo Tanaka, Thilo Dörk, Natalia V. Bogdanova, Sonja Helbig, Annika Lindblom, Sara Margolin, Arto Mannermaa, Vesa Kataja, Veli Matti Kosma, Jaana M. Hartikainen, Anna H. Wu, Chiu Chen Tseng, David Van Den Berg, Daniel O. Stram, Diether Lambrechts, Hui Zhao, Caroline Weltens, Erik Van Limbergen, Jenny Chang-Claude, Dieter Flesch-Janys, Anja Rudolph, Petra Seibold, Paolo Radice, Paolo Peterlongo, Monica Barile, Fabio Capra, Fergus J. Couch, Janet E. Olson, Emily Hallberg, Celine Vachon, Graham G. Giles, Roger L. Milne, Catriona McLean, Christopher A. Haiman, Brian E. Henderson, Fredrick Schumacher, Loic Le Marchand, Jacques Simard, Mark S. Goldberg, France Labrèche, Martine Dumont, Soo Hwang Teo, Cheng Har Yip, Mee Hoong See, Belinda Cornes, Ching Yu Cheng, M. Kamran Ikram, Vessela Kristensen, Wei Zheng, Sandra L. Halverson, Martha Shrubsole, Jirong Long, Robert Winqvist, Katri Pylkäs, Arja Jukkola-Vuorinen, Saila Kauppila, Irene L. Andrulis, Julia A. Knight, Gord Glendon, Sandrine Tchatchou, Peter Devilee, Robert A.E.M. Tollenaar, Caroline Seynaeve, Christi J. Van Asperen, Montserrat García-Closas, Jonine Figueroa, Stephen J. Chanock, Jolanta Lissowska, Kamila Czene, Daniel Klevebring, Hatef Darabi, Mikael Eriksson, Maartje J. Hooning, Antoinette Hollestelle, John W.M. Martens, J. Margriet Collée, Per Hall, Jingmei Li, Keith Humphreys, Xiao Ou Shu, Wei Lu, Yu Tang Gao, Hui Cai, Angela Cox, Simon S. Cross, Malcolm W.R. Reed, William Blot, Lisa B. Signorello, Qiuyin Cai, Mitul Shah, Maya Ghoussaini, Daehee Kang, Ji Yeob Choi, Sue K. Park, Dong Young Noh, Mikael Hartman, Hui Miao, Wei Yen Lim, Anthony Tang, Ute Hamann, Diana Torres, Anna Jakubowska, Jan Lubinski, Katarzyna Jaworska, Katarzyna Durda, Suleeporn Sangrajrang, Valerie Gaborieau, Paul Brennan, James McKay, Curtis Olswold, Susan Slager, Amanda E. Toland, Drakoulis Yannoukakos, Chen Yang Shen, Pei Ei Wu, Jyh Cherng Yu, Ming Feng Hou, Anthony Swerdlow, Alan Ashworth, Nick Orr, Michael Jones, Guillermo Pita, M. Rosario Alonso, Nuria Álvarez, Daniel Herrero, Daniel C. Tessier, Daniel Vincent, Francois Bacot, Craig Luccarini, Caroline Baynes, Shahana Ahmed, Catherine S. Healey, Melissa A. Brown, Bruce A.J. Ponder, Georgia Chenevix-Trench, Deborah J. Thompson, Stacey L. Edwards, Douglas F. Easton, Alison M. Dunning, Juliet D. French
  • Queensland Institute of Medical Research
  • University of Cambridge
  • University of Queensland
  • Antoni van Leeuwenhoek Hospital
  • Centre for Epidemiology and Biostatistics
  • University of Melbourne
  • Sanquin Research
  • University of Warwick
  • University of Manchester
  • Ministry of Public Health
  • Friedrich-Alexander University Erlangen-Nürnberg
  • University of California at Los Angeles
  • London School of Hygiene and Tropical Medicine
  • Institute of Cancer Research
  • Guy’s Hospital
  • University of Oxford
  • University Hospital Galway
  • Heidelberg University 
  • German Cancer Research Center
  • Institut national de la santé et de la recherche médicale
  • Occupational and Social Determinants of Health
  • Copenhagen University Hospital – Herlev and Gentofte
  • University of Copenhagen
  • Centro de Investigación en Red de Enfermedades Raras
  • Hospital Universitario La Paz
  • Hospital Monte Naranco
  • University of California at Irvine
  • City of Hope National Med Center
  • Saarland Cancer Registry
  • Technical University of Munich
  • University of Cologne
  • Universität zu Köln
  • University of Tübingen
  • Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
  • Evangelical Clinics of Bonn
  • Ruhr University Bochum
  • University of Hamburg
  • University of Helsinki
  • Helsinki University Hospital
  • Kyushu University
  • Aichi Cancer Center Hospital and Research Institute
  • Hannover Medical School
  • Karolinska Institutet
  • University of Eastern Finland
  • Peter Maccallum Cancer Centre
  • Keck School of Medicine of USC
  • KU Leuven
  • Flanders Institute for Biotechnology
  • University Hospitals Leuven
  • IRCCS Fondazione Istituto Neurologico Carlo Besta - Milano
  • Istituto Fondazione Italiana per la Ricerca sul Cancro di Oncologia Molecolare
  • European Institute of Oncology
  • Cogentech Cancer Genetic Test Laboratory
  • Mayo Clinic Rochester, MN
  • Cancer Council Victoria
  • Anatomical Pathology
  • University of Hawaii Cancer Center
  • Research Center
  • McGill University Health Centre, Royal Victoria Hospital
  • McGill University
  • University of Montreal
  • Sime Darby Medical Centre
  • University of Malaya
  • National University of Singapore
  • University of Oslo
  • University of Bergen
  • University Hospital of North Norway
  • University of Tromsø – The Arctic University of Norway
  • Vanderbilt University Medical Center
  • University of Oulu
  • Oulu University Hospital
  • University of Toronto
  • Leiden University
  • Netherlands Cancer Institute
  • National Cancer Institute (NCI)
  • Maria Sklodowska-Curie Institute of Oncology
  • Erasmus MC Cancer Institute
  • Erasmus University Rotterdam
  • Genome Institute of Singapore
  • Shanghai Center for Disease Control and Prevention
  • Shanghai Cancer Institute
  • University of Sheffield
  • International Epidemiology Institute
  • Seoul National University
  • MOH Holdings Pte Ltd.
  • Pomeranian Medical University in Szczecin
  • The National Cancer Institute
  • International Agency for Research on Cancer
  • Ohio State University
  • Demokritos National Centre for Scientific Research
  • Academia Sinica - Institute of Biomedical Sciences
  • China Medical University Taichung
  • Tri-Service General Hospital
  • Kaohsiung Medical University Chung-Ho Memorial Hospital

Research output: Contribution to journalArticlepeer-review

68 Scopus citations

Abstract

Genome-wide association studies (GWASs) have revealed SNP rs889312 on 5q11.2 to be associated with breast cancer risk in women of European ancestry. In an attempt to identify the biologically relevant variants, we analyzed 909 genetic variants across 5q11.2 in 103,991 breast cancer individuals and control individuals from 52 studies in the Breast Cancer Association Consortium. Multiple logistic regression analyses identified three independent risk signals: the strongest associations were with 15 correlated variants (iCHAV1), where the minor allele of the best candidate, rs62355902, associated with significantly increased risks of both estrogen-receptor-positive (ER+: odds ratio [OR] = 1.24, 95% confidence interval [CI] = 1.21-1.27, ptrend = 5.7 × 10-44) and estrogen-receptor-negative (ER-: OR = 1.10, 95% CI = 1.05-1.15, ptrend = 3.0 × 10-4) tumors. After adjustment for rs62355902, we found evidence of association of a further 173 variants (iCHAV2) containing three subsets with a range of effects (the strongest was rs113317823 [pcond = 1.61 × 10-5]) and five variants composing iCHAV3 (lead rs11949391; ER+: OR = 0.90, 95% CI = 0.87-0.93, pcond = 1.4 × 10-4). Twenty-six percent of the prioritized candidate variants coincided with four putative regulatory elements that interact with the MAP3K1 promoter through chromatin looping and affect MAP3K1 promoter activity. Functional analysis indicated that the cancer risk alleles of four candidates (rs74345699 and rs62355900 [iCHAV1], rs16886397 [iCHAV2a], and rs17432750 [iCHAV3]) increased MAP3K1 transcriptional activity. Chromatin immunoprecipitation analysis revealed diminished GATA3 binding to the minor (cancer-protective) allele of rs17432750, indicating a mechanism for its action. We propose that the cancer risk alleles act to increase MAP3K1 expression in vivo and might promote breast cancer cell survival.

Original languageEnglish
Pages (from-to)5-20
Number of pages16
JournalAmerican Journal of Human Genetics
Volume96
Issue number1
DOIs
StatePublished - 08 Jan 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1'. Together they form a unique fingerprint.

Cite this